HealthEquity initiated with a Sell at Goldman Sachs 07/12 HQY Goldman Sachs analyst Cindy Motz initiated coverage of HealthEquity with a Sell rating and $59 price target. Investors have viewed the stock as a play on higher interest rates which has benefited the company in prior rising interest rate cycles, but HealthEquity has commented that it does not expect to see a huge lift from rising interest rates any time soon, Motz tells investors in a research note. The analyst is not convinced the company's organic health savings account growth will be enough to support current valuations.
me vs GS-- who won last time? Me. (on the oil price)